The European Prevention of Alzheimer’s Dementia (EPAD) project is very pleased to announce the external release of its final dataset for all researchers from over the world. The final dataset is called Version.IMI (V.IMI) as it represents all the data collected and processed during the IMI period of EPAD. A key achievement of the EPAD…
DetailsA conference blog about the 13th Clinical Trials on Alzheimer’s Disease (CTAD) conference which took online, from 4-7 November 2020, has been published on the AlzForum website. The article mentions EPAD and can be read below: EPAD had been supported for five years by the Innovative Medicines Initiative (IMI), which is funded jointly by the…
DetailsA key achievement of the EPAD project was the establishment of a Longitudinal Cohort Study (LCS) that has screened over 2,000 participants and collected a wide range of cognitive, clinical, neuroimaging and biomarker data to help further our understanding of the early stages of Alzheimer’s disease. “We aim to ensure that this precious collection of…
DetailsThe Alzheimer’s Disease Data Initiative (ADDI) has launched its Alzheimer’s disease (AD) Workbench, a cloud-based platform for scientists to accelerate discoveries and innovations for AD and related dementias. ADDI is a new global effort that aims to advance AD innovation by connecting researchers with the data needed to generate insights and inform the development of improved…
DetailsThe EPAD team has published a new paper entitled “Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study” in the journal Alzheimer’s Research Therapy. In this paper, authors from the University of Oxford and the Alzheimer Center Amsterdam tested the predictive utility of…
DetailsThe Alzheimer’s Disease Data Initiative (ADDI) aims to move Alzheimer’s disease (AD) innovation further and faster by connecting researchers with the data they need to generate insights to inform development of new, better treatments and diagnostic tools for AD and related dementias. We are pleased that ADDI is supporting the EPAD project. In 2016, EPAD…
DetailsThe 30th Alzheimer Europe Conference (#30AEC) “Dementia in a changing world” was held online from 20-22 October 2020. Almost 800 participants, from 42 countries, attended the conference, which boasted 260 speakers and 100 poster presentations, sharing their research, projects and experiences in an atmosphere of collaboration and solidarity, against the backdrop of the global COVID-19…
DetailsCould you tell us a bit about you and your work? My background lies in the fields of neurobiology and neuropsychology, and I am currently a PhD student at Barcelonabeta Brain Research Center. My research focuses on the study of fluid biomarker profiles in preclinical Alzheimer’s disease, as well as on the effect of modifiable…
DetailsThe EPAD Registry was set up as an innovative framework to find participants for the EPAD studies from Parent Cohorts (PCs) across Europe. Making this work in practise has required the creation and optimisation of an array of software tools including the SEEPAD tool for monitoring the EPAD Registry workflows and recruitment (‘Subject Enrolment in…
DetailsOn 15 October, a new paper entitled “Involving research participants in a pan-European research initiative: the EPAD participant panel experience” has been published in the journal Research Involvement and Engagement. One of the founding goals of the EPAD programme was to involve participants as research partners. EPAD set up a series of ‘participant panels’ in…
Details
